Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?
Botticelli A, Cerbelli B, Lionetto L, Zizzari I, Salati M, Pisano A, Federica M, Simmaco M, Nuti M, Marchetti P. Botticelli A, et al. Among authors: nuti m. J Transl Med. 2018 Aug 6;16(1):219. doi: 10.1186/s12967-018-1595-3. J Transl Med. 2018. PMID: 30081936 Free PMC article.
Immune effects of trastuzumab.
Nuti M, Bellati F, Visconti V, Napoletano C, Domenici L, Caccetta J, Zizzari IG, Ruscito I, Rahimi H, Benedetti-Panici P, Rughetti A. Nuti M, et al. J Cancer. 2011;2:317-23. doi: 10.7150/jca.2.317. Epub 2011 May 25. J Cancer. 2011. PMID: 21716848 Free PMC article.
HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy.
Zizzari IG, Veglia F, Taurino F, Rahimi H, Quaglino E, Belleudi F, Riccardo F, Antonilli M, Napoletano C, Bellati F, Benedetti-Panici P, Torrisi MR, Frati L, Nuti M, Rughetti A. Zizzari IG, et al. Among authors: nuti m. J Mol Med (Berl). 2011 Dec;89(12):1231-40. doi: 10.1007/s00109-011-0794-7. Epub 2011 Aug 16. J Mol Med (Berl). 2011. PMID: 21845448 Free PMC article.
Monoclonal antibodies in gynecological cancer: a critical point of view.
Bellati F, Napoletano C, Gasparri ML, Visconti V, Zizzari IG, Ruscito I, Caccetta J, Rughetti A, Benedetti-Panici P, Nuti M. Bellati F, et al. Among authors: nuti m. Clin Dev Immunol. 2011;2011:890758. doi: 10.1155/2011/890758. Epub 2011 Dec 26. Clin Dev Immunol. 2011. PMID: 22235224 Free PMC article. Review.
MGL Receptor and Immunity: When the Ligand Can Make the Difference.
Zizzari IG, Napoletano C, Battisti F, Rahimi H, Caponnetto S, Pierelli L, Nuti M, Rughetti A. Zizzari IG, et al. Among authors: nuti m. J Immunol Res. 2015;2015:450695. doi: 10.1155/2015/450695. Epub 2015 Dec 29. J Immunol Res. 2015. PMID: 26839900 Free PMC article. Review.
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial.
Antonilli M, Rahimi H, Visconti V, Napoletano C, Ruscito I, Zizzari IG, Caponnetto S, Barchiesi G, Iadarola R, Pierelli L, Rughetti A, Bellati F, Panici PB, Nuti M. Antonilli M, et al. Among authors: nuti m. Int J Oncol. 2016 Apr;48(4):1369-78. doi: 10.3892/ijo.2016.3386. Epub 2016 Feb 8. Int J Oncol. 2016. PMID: 26892612 Free PMC article. Clinical Trial.
279 results